EOSURGICAL LIMITED

 

Registered number: SC415155 (Scotland)

 

Unaudited financial statements

 

For the year ended 31 January 2024

EOSURGICAL LIMITED

 

CONTENTS OF THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JANUARY 2024

 

 

Page

  

Company Information

1

  

Balance Sheet

2-3

  

Notes to the Financial Statements

4-6

 

EOSURGICAL LIMITED

 

COMPANY INFORMATION

FOR THE YEAR ENDED 31 JANUARY 2024

 

Directors

Paul Martin Brennan (resigned 4 July 2023)

 

Mark Hughes (resigned 4 July 2023)

 

Roland Partridge (resigned 4 July 2023)

 

Nicholas Hull (appointed 4 July 2023)

  

Registered number

SC415155 (Scotland)

  

Registered office

272 Bath Street

 

Glasgow

 

G2 4JR

 

Scotland

 

EOSURGICAL LIMITED

 

BALANCE SHEET

AS AT 31 JANUARY 2024

 

  

2024

2023

 

Notes

£

£

Fixed assets

   

Intangible assets

4

-

31

Tangible assets

5

 

1,057

    
  

-

1,088

Current assets

   

Inventories

 

-

15,000

Debtors

6

78,572

27,506

Cash at bank and in hand

 

-

27,167

    
  

78,572

69,673

Creditors: amounts falling due within one year

7

-

(13,424)

    

Net current assets

 

78,572

56,249

    

Total assets less current liabilities

 

78,572

57,337

    

Provisions for liabilities

   

Deferred tax

 

-

(313)

    

Net assets

 

78,572

57,024

    

Capital and reserves

   

Call up share capital

 

781

781

Profit and loss account

 

77,791

56,243

    

Shareholders’ funds

 

78,572

57,024

 

The company is entitled to exemption from audit under section 479A of the Companies Act 2006 relating to subsidiary companies for the year ended 31 January 2024.

 

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2024 in accordance with Section 476 of the Companies Act 2006.

 

The directors acknowledge their responsibilities for:

 

(a)

ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

 

EOSURGICAL LIMITED

 

BALANCE SHEET

AS AT 31 JANUARY 2024

 

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies’ regime.

 

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

 

The financial statements were approved by the Board of Directors and authorised for issue on 27th July 2024 and were signed on its behalf by:

 

 

 

 

 

 

Nicholas Hull-Director

EOSURGICAL LIMITED

 

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JANUARY 2024

 

1.     Statutory Information

 

eosurgical Limited is a private company, limited by shares, registered in Scotland, registration number SC415155. The registered office is 272 Bath Street, Glasgow, G2 4JR, Scotland.

 

The shares of the company were acquired by Limbs & Things Limited on 4,h July 2023, following which the trade and assets of the company were hived-up to the parent company, and trading with the company has now ceased.

 

2.     Compliance with accounting standards

 

The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.

 

3.     Accounting policies

 

Basis of preparation

The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.

 

Presentation currency

The accounts are presented in £ sterling.

 

4.     Intangible fixed assets

 

 

Other

Cost

£

At 1 February 2023

31

Transfer to parent company post-acquisition

(31)

  

At 31 January 2024

-

  

Amortisation

 

At 1 February 2023

-

  

At 31 January 2024

-

  

Net book value

 

At 31 January 2024

-

  

At 31 January 2023

31

EOSURGICAL LIMITED

 

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JANUARY 2024

 

5.     Tangible fixed assets

 

 

Office

Fixtures &

Computer

 
 

equipment

fittings

equipment

Total

Cost or valuation

£

£

£

£

     

At 1 February 2023

-

966

20,492

21,458

Additions

1,139

-

5,587

6,726

Disposals

-

(966)

(17,966)

(18,932)

Transfer to parent company post-acquisition

(1,139)

-

(8,113)

(9,252)

     

At 31 January 2024

-

-

-

-

     

Depreciation

    
     

At 1 February 2023

-

941

19,460

20,401

Charge for the year

89

25

869

983

Disposals

-

(966)

(17,966)

(18,932)

Transfer to parent company post-acquisition

(89)

-

(2,363)

(2,452)

     

At 31 January 2024

-

-

-

-

     

Net book value

    

At 31 January 2024

-

-

-

-

     

At 31 January 2023

-

25

1,032

1,057

 

6.     Debtors

 

 

2024

2023

 

£

£

Trade debtors

-

20,352

Amounts owed by group undertakings

78,572

-

Other debtors

 

7,154

   
 

78,572

27,506

EOSURGICAL LIMITED

 

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JANUARY 2024

 

7.     Creditors: amounts falling due within one year

 

 

2024

2023

 

£

£

   

Trade creditors

-

1,632

VAT

-

2,349

Taxes and social security

-

(73)

Other creditors

-

8,387

Loans from directors

-

1,129

   
 

-

13,424

 

8.     Average number of employees

 

During the year the average number of employees was 3 (2023 - 5).

 

9.     Related party disclosures

 

The immediate and ultimate parent company is Limbs & Things Limited.

 

Limbs & Things Limited is the smallest and largest group for which consolidated financial statements are prepared. The registered office of Limbs & Things Limited is Sussex Street, St Philips, Bristol BS2 ORA and accounts are freely available from Companies House.

 

No one person is deemed to have control of the company.

 

The company is exempt from disclosing other related party transactions as they are with other companies that are wholly owned within the Limbs & Things Limited group.

true